Načítá se...
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors
Aim: We report, herein, three cases of pleomorphic carcinoma of the lung treated with immune checkpoint inhibitors. Case 1: A 73-year-old man was diagnosed as having pleomorphic carcinoma of the lung and treated with pembrolizumab alone. However, he showed no response and died 4 months after the ini...
Uloženo v:
| Vydáno v: | In Vivo |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Institute of Anticancer Research
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193335/ https://ncbi.nlm.nih.gov/pubmed/33910853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12428 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|